期刊文献+

超声引导下Mammotome微创旋切系统在乳腺良性病变切除术中的应用 被引量:2

Applicantion of ultrasound-guided vacuum-assisted biopsy (mammotome) in breast benign lesions
暂未订购
导出
摘要 目的探讨超声引导下Mammotome微创旋切系统在切除乳腺良性病变中的应用价值。方法 86例乳腺肿瘤患者,115个乳腺肿块,经超声或X线钼靶检查,结合临床初步诊断为良性病变,在超声引导下应用Mammotome微创旋切系统治疗,同时行病理检查。结果乳腺病灶在超声引导下均被完全切除,每个肿块手术时间(20±10)min,平均旋切次数15次,皮肤切口0.25~0.4cm。1例出现切口下血肿,2个月后完全吸收,5例出现皮下淤血癍,未见感染。结论超声引导下Mammotome微创旋切乳腺良性病变,具有创伤小、并发症少、恢复快、乳房表面不留疤痕等优点,是一种值得推广的乳腺病变微创治疗方法。 Objective To evaluate the clinical application of ultrasound - guided vacuum - assisted biopsy (mammotome) in breast benign lesions. Methods The operations and biopsy of 115 breast lesions in 86 patients were performed by ultrasound - guided vacuum - assisted biopsy (mammotome). Results All of breast masses were resected completely. The operative time was 20 ± 10 min. The length of incision was only 0.25 - 0.4cm. Five cases were with local congestion,1 case with haematoma under incision. No infection was found. Conclusion Mammotome operation shows many benefits as less trauma ,fewer complications and more rapid recovery with scar- free breast skin,It is a useful minimally invasive treatment of breast benign lesions.
出处 《临床超声医学杂志》 2011年第1期54-55,共2页 Journal of Clinical Ultrasound in Medicine
关键词 MAMMOTOME微创旋切系统 超声引导 乳腺肿瘤 良性 Mammotome minimal invasive system Uhrasound -guided Breast tumor, benign
  • 相关文献

参考文献1

二级参考文献31

  • 1[29]Bryant J,Clegg AJ,Sidhu MK,Brodin H,Royle P,Davidson P.Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei.Health Technol Assess 2004; 8:iii,1-54
  • 2[30]Gomez Portilla A,Deraco M,Sugarbaker PH.Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer:guidelines for current practice.Tumori 1997; 83:725-728
  • 3[31]Deraco M,Rossi CR,Pennacchioli E,Guadagni S,Somers DC,Santoro N,Raspagliesi F,Kusamura S,Vaglini M.Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer:a phase Ⅱ clinical study.Tumori 2001; 87:120-126
  • 4[1]Werth R.Pseudomyxoma peritonei.Arch Gynaecol 1884; 24:100-118
  • 5[2]van Ruth S,Acherman YI,van de Vijver MJ,Hart AA,Verwaal VJ,Zoetmulder FA.Pseudomyxoma peritonei:a review of 62 cases.Eur J Surg Oncol 2003; 29:682-688
  • 6[3]Sugarbaker PH.Pseudomyxoma peritonei.A cancer whose biology is characterized by a redistribution phenomenon.Ann Surg 1994; 219:109-111
  • 7[4]Deraco M,Santoro N,Carraro O,Inglese MG,Rebuffoni G,Guadagni S,Somers DC,Vaglini M.Peritoneal carcinomatosis:feature of dissemination.A review.Tumori 1999; 85:1-5
  • 8[5]Moran BJ,Cecil TD.The etiology,clinical presentation,and management of pseudomyxoma peritonei.Surg Oncol Clin N Am 2003; 12:585-603
  • 9[6]Sugarbaker PH.Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma.Eur J Surg Suppl 1991; 561:75-82
  • 10[7]Panteix G,Guillaumont M,Cherpin L,Cuichard J,Gilly FN,Carry PY,Sayag A,Salle B,Brachet A,Bienvenu J.Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues.Oncology 1993; 50:366-370

共引文献10

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部